XML 66 R55.htm IDEA: XBRL DOCUMENT v3.25.3
Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Sep. 30, 2024
Schedule of Accrued Expenses and Other Current Liabilities [Abstract]      
Accrued research and development expense $ 1,773,583 $ 1,799,583  
Accrued directors and officers (owners) compensation 995,097 1,025,867  
Cash portion of the Lind Note repayments 492,376 127,759  
Accrued compensation and employee benefits 154,780 126,106  
Others 575,578 430,107  
Total $ 3,991,414 $ 3,509,422 $ 3,590,301